4//SEC Filing
GRIFFIN BRIAN T 4
Accession 0001596771-20-000001
CIK 0001610092other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 7:05 PM ET
Size
8.1 KB
Accession
0001596771-20-000001
Insider Transaction Report
Form 4
GRIFFIN BRIAN T
DirectorChairman and CEO
Transactions
- Award
Common Stock
2020-02-04+583,580→ 815,308 total(indirect: By Trust) - Award
Common Stock
2020-02-04+613,372→ 1,428,680 total(indirect: By Trust)
Holdings
- 11,238
Common Stock
Footnotes (4)
- [F1]On June 4, 2018, reporting person was granted restricted stock units that were subject to the Issuer's satisfaction of certain financial performance criteria. On February 4, 2020 (the "determination date"), the performance criteria was met with respect to 583,580 restricted stock units all of which vested upon the determination date.
- [F2]These shares are held by the Brian T. Griffin 2019 Grantor Retained Annuity Trust No. II.
- [F3]On June 4, 2019, reporting person was granted restricted stock units that were subject to the Issuer's satisfaction of certain financial performance criteria. On February 4, 2020 (the "determination date"), the performance criteria was met with respect to 613,372 restricted stock units. One-third of the restricted stock units vested upon the determination date, and the remaining two-thirds will vest in two equal installments on each anniversary of the determination date, subject to continued employment.
- [F4]Represents shares received upon the vesting of a portion of an inducement award of stock granted to the reporting person in connection with his appointment as CEO and Chairman, granted on June 4, 2018.
Documents
Issuer
Diplomat Pharmacy, Inc.
CIK 0001610092
Entity typeother
Related Parties
1- filerCIK 0001252006
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 7:05 PM ET
- Size
- 8.1 KB